Literature DB >> 19602137

Chronic hepatitis C virus infection associated with autonomic dysfunction.

János Osztovits1, Tamás Horváth, Margit Abonyi, Tamás Tóth, Zsolt Visnyei, Gabriella Bekö, Tímea Csák, Péter László Lakatos, Levente Littvay, János Fehér, Péter Kempler, Márk Kollai, Ferenc Szalay.   

Abstract

BACKGROUND: Impaired autonomic function has been described in patients with chronic liver diseases from different aetiologies, and has proven to be a poor prognostic indicator. To date, it is not known how chronic hepatitis C virus (HCV) infection affects the autonomic nervous system. AIMS: In the present study, we compared cardiovagal autonomic function in patients with chronic HCV infection and healthy controls and examined the relation between autonomic function and serum levels of aminotransferases, HCV RNA, cryoglobulins, albumin and glucose.
METHODS: Autonomic function was assessed in 45 treatment-naïve patients with chronic HCV infection and in 40 healthy controls by determining spontaneous baroreflex sensitivity (BRS) and heart rate variability (HRV) indices. The R-R interval was determined by electrocardiogram recording; continuous radial artery pressure was monitored simultaneously by applanation tonometry. Laboratory analyses and quantitative polymerase chain reaction for serum HCV RNA level were performed by standard procedures.
RESULTS: BRS and HRV time and frequency domain indices were lower in patients with HCV infection compared with healthy controls [7.1+/-3.4 vs. 11.5+/-6.5 ms/mmHg for BRS, 168.5+/-160.9 vs. 370.7+/-349.4 ms(2) for low-frequency HRV (mean+/-SD); P<0.01]. Multivariate analysis showed that autonomic dysfunction in HCV-infected patients correlated with elevated alanine aminotransferase levels, but was not associated with serum HCV RNA levels and cryoglobulins.
CONCLUSION: Our results suggest that impaired autonomic function is caused by chronic HCV infection. Further studies are needed, however, to identify the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602137     DOI: 10.1111/j.1478-3231.2009.02075.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  10 in total

1.  [Achalasia in a patient with HIV/HCV coinfection: detection of HCV in the esophageal tissue].

Authors:  H R Gockel; I Gockel; D G Drescher; H Müller; A Schad; J M Kittner; H Rossmann; H Lang
Journal:  Chirurg       Date:  2011-11       Impact factor: 0.955

2.  Cardiac autonomic modulation in children with severe liver disease, before and after liver transplantation.

Authors:  Renata Salatini; Joice Amaral; Rodrigo Daminello Raimundo; Fernando Rocha; Luiz Carlos de Abreu; Mauro Morais; Uenis Tannuri; Ana Cristina Tannuri
Journal:  Transl Pediatr       Date:  2022-04

Review 3.  Autonomic Dysfunction during Acute SARS-CoV-2 Infection: A Systematic Review.

Authors:  Irene Scala; Pier Andrea Rizzo; Simone Bellavia; Valerio Brunetti; Francesca Colò; Aldobrando Broccolini; Giacomo Della Marca; Paolo Calabresi; Marco Luigetti; Giovanni Frisullo
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

4.  Cardiovascular risk assessment by electrocardiographic Holter monitoring in patients with chronic hepatitis C.

Authors:  Adam R Poliwczak; Jolanta Białkowska; Joanna Woźny; Marzena Koziróg; Agnieszka Bała; Maciej Jabłkowski
Journal:  Arch Med Sci       Date:  2020-07-15       Impact factor: 3.318

Review 5.  Shared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research.

Authors:  Victoria Menzies; Nancy Jallo; Patricia Kinser; Jo Lynne W Robins; Kyungeh An; Carolyn Driscoll; Angela Starkweather; Jasmohan S Bajaj; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2014-07-18       Impact factor: 2.522

Review 6.  Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Bruno Sangro; Stephen L Chan; Tim Meyer; María Reig; Anthony El-Khoueiry; Peter R Galle
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

7.  Reversible autonomic dysfunction during antiviral treatment in patients with chronic hepatitis C virus infection: Anti-HCV therapy and autonomic function.

Authors:  Janos Osztovits; Evelin Horvath; Judit Tax; Levente Csihi; Tamas Horvath; Levente Littvay; Tamas Toth; Margit Abonyi; Peter L Lakatos; Mark Kollai; Janos Feher; Ferenc Szalay; Hubert E Blum
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

8.  Alteration of Autonomic Nervous System Is Associated With Severity and Outcomes in Patients With COVID-19.

Authors:  Yuchen Pan; Zhiyao Yu; Yuan Yuan; Jiapeng Han; Zhuo Wang; Hui Chen; Songyun Wang; Zhen Wang; Huihui Hu; Liping Zhou; Yanqiu Lai; Zhen Zhou; Yuhong Wang; Guannan Meng; Lilei Yu; Hong Jiang
Journal:  Front Physiol       Date:  2021-05-19       Impact factor: 4.566

9.  Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.

Authors:  Sanja Glišić; David P Cavanaugh; Krishnan K Chittur; Milan Sencanski; Vladimir Perovic; Tijana Bojić
Journal:  BMC Bioinformatics       Date:  2016-03-22       Impact factor: 3.169

10.  Changes in Office Blood Pressure Control, Augmentation Index, and Liver Steatosis in Kidney Transplant Patients after Successful Hepatitis C Infection Treatment with Direct Antiviral Agents.

Authors:  Aureliusz Kolonko; Joanna Musialik; Jerzy Chudek; Magdalena Bartmańska; Natalia Słabiak-Błaż; Agata Kujawa-Szewieczek; Piotr Kuczera; Katarzyna Kwiecień-Furmańczuk; Andrzej Więcek
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.